IP Library Assignment 059034/0319
Patent Assignment
Reel/Frame 059034/0319

Assignment of Assignor's Interest

Recorded: 2022-02-17 Pages: 8
Assignors
SHU, DONGXU
Executed: 2019-10-03
NICHOLAS, ANTHONY
Executed: 2019-10-03
CARLSON, JEFFREY
Executed: 2019-10-03
LI, XIAOKAI
Executed: 2019-10-03
ALTENHOFER, ERICH
Executed: 2019-09-11
FOWLER-WATTERS, MATTHEW
Executed: 2019-10-03
CHEN, BO
Executed: 2019-09-11
WONG, SO
Executed: 2019-10-03
Assignee
ARROWHEAD PHARMACEUTICALS, INC.
225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CALIFORNIA, 91101
Covered Property (1)
RNAi Agents for Inhibiting Expression of HIF-2 alpha (EPAS1), Compositions Thereof, and Methods of Use
Application: 17/420,460 →
Publication: US 2022/0204976
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 17, 2022
From: LI, ZHEN
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 059034/0092 →
Assignment of Assignor's Interest Feb 17, 2022
From: ZHU, RUI
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 059034/0192 →
Security Interest Aug 7, 2024
From: ARROWHEAD PHARMACEUTICALS, INC.
To: SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT
Reel/Frame 068510/0363 →